Navigation Links
Milwaukee area biotech ZyStor seeks more funding

Wauwatosa, Wis. ZyStor Therapeutics, Inc. will seek additional venture funding this year in advance of filing for an investigational new drug application, president and CEO Loren G. Peterson said.

Peterson explained the company's plans during an informal gathering at the Innovation Monday program. He said ZyStor, which is developing enzyme repl......

Full article >>> painful disabilities.

Such disabilities are rare, but those afflicted can die at an early age, and existing drug therapies have proven inadequate. "I think one child born in Wisconsin each year has an LSD, which is how rare they are," Peterson said.

To be effective, the therapeutic enzyme must be delivered to the appropriate cells in tissues where the storage defect manifests its......

Full article >>> he disease. Genzyme Corp., the Massachusetts life science company that acquired Madison's Bone Care International, has built a $2.7 billion corporation on the treatment of rare genetic diseases, Broderick noted.

ZyStor hopes to partner with leading pharmaceutical companies for the development of enzyme replacement therapies. The company has an RFP out to prospective clinical contract manu......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 04/18/06


Related biology technology :

1. Bruce Maas named CIO at UW-Milwaukee
2. Milwaukee takes another step in electronic patient data exchange
3. Company still behind schedule on Milwaukee wireless project
4. Chicago-Milwaukee "mega-metro" infrastructure improvements are critical
5. Milwaukee software developer gains bottom line, loses waistline
6. Education is fundamental to Milwaukees growth
7. Grow Milwaukee includes millions for tech funding
8. AT&T tech rollout will bring 200 jobs to Milwaukee
9. Bandwidth provider expands in Milwaukee
10. Handicapping Milwaukees wireless initiative
11. Businesses could bridge digital divide in Milwaukee with used computers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/22/2017)... CAMBRIDGE, Mass. , March 22, 2017   ... of next-generation cancer therapeutics designed to target cancer stemness ... Patricia S. Andrews as Chief Executive Officer, ... will succeed Chiang J. Li , M.D., FACP, ... company ten years ago. Under his leadership, Boston Biomedical ...
(Date:3/22/2017)... ... March 21, 2017 , ... Benchworks CEO Thad ... Officer Forum on March 23-24 in San Diego. The event is a gathering ... industries. , Benchworks Vice President Christian Meyer will also participate in the forum. ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Society for Immunotherapy of Cancer ... in the Administration’s recently published fiscal year 2018 budget request. , This ... (NIH) by $5.8 billion or roughly 20% of its total budget. If applied proportionally ...
(Date:3/22/2017)... 2017   Invitae Corporation (NYSE: NVTA), ... today announced the availability of a new genetic ... Atrophy (SMA) , a neuromuscular disease that is ... infants as well as a significant cause of ... announced during the American College of Medical Genetics ...
Breaking Biology Technology:
(Date:3/22/2017)... 2017   Neurotechnology , a provider of ... announced the release of the SentiVeillance 6.0 ... facial recognition using up to 10 surveillance, security ... The new version uses deep neural-network-based facial detection ... utilizes a Graphing Processing Unit (GPU) for enhanced ...
(Date:3/20/2017)... -- PMD Healthcare announces the release of its new ... (WMS), a remote, real-time lung health monitoring and management ... a Medical Device, Digital Health, and Chronic Care Management ... solutions that empower people to improve their healthcare and ... the first ever personal spirometer, Spiro PD, which was ...
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. ... "Eating Well Made Simple," and 23andMe , the ... guide better food choices.  Zipongo can now provide customers ... food preferences, health goals and biometrics, but also genetic ... food choices. Zipongo,s personalized food decision support ...
Breaking Biology News(10 mins):